A Review of Cardiac Amyloidosis: Presentation, Diagnosis, and Treatment.
Journal
Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
15
08
2022
accepted:
16
08
2022
pubmed:
23
8
2022
medline:
9
11
2022
entrez:
22
8
2022
Statut:
ppublish
Résumé
Amyloidosis is a group of disorders that can affect almost any organ due to the misfolding of proteins with their subsequent deposition in various tissues, leading to various disease manifestations based on the location. When the heart is involved, amyloidosis can manifest with a multitude of presentations such as heart failure, arrhythmias, orthostatic hypotension, syncope, and pre-syncope. Diagnosis of cardiac amyloidosis can be difficult due to the non-specific nature of symptoms and the relative rarity of the disease. Amyloidosis can remain undiagnosed for years, leading to its high morbidity and mortality due to this delay in diagnosis. Newer imaging modalities, such as cardiac magnetic resonance imaging, advanced echocardiography, and biomarkers, make a timely cardiac amyloidosis diagnosis more feasible. Many treatment options are available, which have provided new hope for this patient population. This manuscript will review the pathology, diagnosis, and treatment options available for cardiac amyloidosis and provide a comprehensive overview of this complicated disease process.
Identifiants
pubmed: 35995246
pii: S0146-2806(22)00263-8
doi: 10.1016/j.cpcardiol.2022.101366
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101366Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.